International organizations, vaccine manufacturers take stock of COVID-19 vaccine rollout, share views on 2022 – Community News
Covid-19

International organizations, vaccine manufacturers take stock of COVID-19 vaccine rollout, share views on 2022

The heads of the International Monetary Fund, the World Bank Group, the World Health Organization and the World Trade Organization held the 2nd High-level consultation with the CEOs of leading manufacturers of COVID-19 vaccines. At the meeting, all participants agreed on the urgency to deliver more vaccine doses to low-income countries, where less than 2.5% of the population is fully vaccinated.

The purpose of the meeting was to determine how to distribute the vaccines more fairly and all participants pledged to continue to work together to clarify donations, vaccine swaps and delivery schedules so that the distribution of the life-saving vaccines can be more effective. targeting countries most in need.

The Multilateral Leaders Task Force meeting on COVID-19 built on technical work performed by multidisciplinary teams during the months of September and October.

During the consultation, the heads of the four organizations and the CEOs also looked at how best to tackle trade-related bottlenecks; how to improve the donation process; what additional steps are needed to meet the vaccination target of 40% of people in all countries by the end of the year; and how to improve transparency and data sharing with the IMF-WHO Vaccine Supply Forecast Dashboard and the Multilateral Leaders Task Force, which require close collaboration between manufacturers, governments and COVAX to improve visibility of delivery schedules, especially for donated doses.

The outlook for 2022 was also discussed, focusing on diversifying production in different regions and strengthening cooperation to achieve the global target of vaccinating 70% of the population of all countries by the middle of the year. The group recognized progress in diversifying manufacturing, with new partnerships in multiple developing countries, and stressed the need to continue strengthening such manufacturing collaboration.

The heads of the organizations encouraged all G20 governments to join efforts to meet the 40% vaccination target by the end of 2021 by allowing manufacturers to prioritize COVAX and African Vaccine Acquisition Trust ( AVAT) contracts; streamlining donations to COVAX and committing more doses; exploring options for effective vaccine swaps with COVAX and the AVAT; and lifting export restrictions on vaccines and their inputs.